Form EFFECT Cogent Biosciences, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 10, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Forum Ventures 2026 Cohort: 64% of Founders Reach Early Revenue
- Top 3 Cryptos to Buy Now as Binance EU License Expires and Pepeto, BNB, and DOGE Face a Turning Point
- Best Crypto to Buy Now as BTC ETF Outflows Hit $469M While Pepeto Crosses $10.3M Before Listing
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
